MBX Biosciences, Inc. MBX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$86.61M+0.4% | -$86.97M-8.0% | -$80.5M-4.5% | -$77.02M-4.8% | -$73.47M-18.6% | ||
| $324K-3.9% | $337K+0.6% | $335K0.0% | $335K0.0% | $335K+9.5% | ||
| $12.32M+42.0% | $8.68M+15.6% | $7.51M+16.3% | $6.46M+18.7% | $5.44M+4.1% | ||
| -$77.48M+3.1% | -$79.95M-2.9% | -$77.69M-9.7% | -$70.81M-6.2% | -$66.65M-21.9% | ||
| $2.34M+21.1% | $1.93M+57.1% | $1.23M+38.6% | $886K+40.4% | $631K-27.8% | ||
| -$184.03M-120% | -$83.71M-297% | -$21.08M+84.8% | -$138.92M+19.6% | -$172.8M-7.6% | ||
| $277.02M+46.1% | $189.59M+0.2% | $189.15M-20.2% | $237.14M+1.3% | $234.06M-0.1% | ||
| —— | —— | —— | —— | —— | ||
| -$79.82M+2.5% | -$81.88M-3.8% | -$78.91M-10.1% | -$71.7M-6.6% | -$67.28M-21.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does MBX Biosciences, Inc.'s cash flow data come from?
- Every line is extracted from MBX Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.